Literature DB >> 16702074

What can acquired nystagmus tell us about congenital forms of nystagmus?

R John Leigh1, Sangeeta Khanna.   

Abstract

For several forms of acquired nystagmus, animal models exist, mathematical hypotheses have been proposed, and treatments are available. What insights could acquired nystagmus provide for congenital forms of nystagmus? Acquired periodic alternating nystagmus (PAN) is caused by instability of the velocity storage mechanism for vestibular eye movements; an adaptive mechanism produces the oscillations that have a period of about 4 minutes. Surprisingly, the ability of individuals with congenital forms of nystagmus to adapt their eye movements to new visual demands has received little study. Acquired pendular nystagmus (APN) may arise from instability in the neural integrator for eye movements; identification of the neurotransmitters contributing to normal gaze holding made it possible to identify candidate drugs for treatment of APN. Similar knowledge of the biology underlying of congenital forms of nystagmus might similarly suggest effective drugs. Downbeat nystagmus (DBN) is caused by cerebellar disease, which includes structural lesions affecting the flocculus and paraflocculus, and calcium channelopathies, such as episodic ataxia type 2 (EA2), for which a mouse model and effective treatment is available. Since some congenital forms of nystagmus are genetic in origin, then the possibility arises that they may be caused by a channelopathy, a hypothesis that suggests novel drugs for evaluation in randomized controlled trials.

Entities:  

Mesh:

Year:  2006        PMID: 16702074     DOI: 10.1080/08820530600613985

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  3 in total

1.  The clinical and molecular genetic features of idiopathic infantile periodic alternating nystagmus.

Authors:  Mervyn G Thomas; Moira Crosier; Susan Lindsay; Anil Kumar; Shery Thomas; Masasuke Araki; Chris J Talbot; Rebecca J McLean; Mylvaganam Surendran; Katie Taylor; Bart P Leroy; Anthony T Moore; David G Hunter; Richard W Hertle; Patrick Tarpey; Andrea Langmann; Susanne Lindner; Martina Brandner; Irene Gottlob
Journal:  Brain       Date:  2011-02-08       Impact factor: 13.501

2.  Anticonvulsant-induced downbeat nystagmus in epilepsy.

Authors:  Dongyan Wu; Roland D Thijs
Journal:  Epilepsy Behav Case Rep       Date:  2015-08-27

3.  Development and clinical utility of a novel diagnostic nystagmus gene panel using targeted next-generation sequencing.

Authors:  Mervyn G Thomas; Gail DE Maconachie; Viral Sheth; Rebecca J McLean; Irene Gottlob
Journal:  Eur J Hum Genet       Date:  2017-04-05       Impact factor: 4.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.